# Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers

> **NCT02253875** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tipranavir (TPV)
- **DRUG:** Ritonavir
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT02253875
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-02
- **Final completion:** —
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02253875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02253875, "Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02253875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*